The growing focus on diabetic foot care, driven by an expanding diabetic population, is propelling the Diabetic Shoes Market toward steady growth. According to a recent analysis by Future Market Insights (FMI), the market is projected to reach a staggering USD 16.0 billion by 2033, surging from its current value of USD 8.6 billion in 2023. This translates to a significant Compound Annual Growth Rate (CAGR) of 6.4%.
This growth is driven by several factors, including the rising prevalence of diabetes and increased public awareness of this chronic illness. As market trends evolve, both the industry and the market are anticipated to experience significant growth in the coming years
Most people in the world are affected by Type 1 and Type 2 diabetes. Problems including neuropathy, loss of feeling, and numbness in the foot are brought on by high blood sugar levels. To prevent foot complications in a diabetic condition, proper foot care is crucial. Due to this high occurrence, medical professionals advise patients to wear diabetic shoes. Additionally, online merchants encourage their customers to purchase these shoes over other types of footwear by emphasizing their optimum effectiveness. Diabetic shoes are a helpful addition to a healthy diet, an active lifestyle, and the right medications for managing diabetes.
The therapeutic shoes’ exceptional comfort, added depth, flexibility, and lightweight qualities, as well as their availability in attractive designs and colors, all contribute to the expansion of the Global Diabetic shoe industry.
Request a Sample Copy PDF of this Diabetic Shoes Market Report!
Key Takeaways from Diabetic Shoes Market Study:
- Based on product type, dress shoe leads the segment with a growth rate of 6.4%. The growing working-class population and the rising demand for trending designs that suit consumer outfits would serve as growth factors.
- Women are more prone to diabetes due to their high SHBG levels. Growing awareness among women to maintain their physique and health would lead them to be the top end-users and lead the segment with a growth rate of 5.8%
- The segment of online retailers is predicted to expand at a phenomenal CAGR of 10.8% throughout the projected period in terms of the sales channel. The segment’s expansion can be attributed to consumers’ increasing preference for online shopping.
- The United States leads the market with a revenue share of US$ 5.7 billion. The population in the United States is more concerned about their health and hygiene, which leads them to spend highly on healthcare solutions.
- China is among the most lucrative countries in the region, contributing a CAGR of 5.8% by 2033. The growing geriatric population is a crucial factor supporting the growth. Investments from various key businesses in the region are likely to serve as a potential opportunity for the market to grow.
Diabetic Shoes Market Competitive Landscape:
To grow their company internationally and gain a competitive edge in the global diabetic shoes market, top diabetic shoe manufacturers have implemented a variety of organic and inorganic strategies, including new product launches, mergers, partnerships, acquisitions, the strengthening of online sales channels, and the establishment of new manufacturing facilities.
Latest Developments in the Diabetic Shoes Market:
- The development of smart footwear was revealed by Sensoria Health and Optima Molliter at the International Consumer Electronics Show (CES) in January 2018. Motus Smart footwear was unveiled by Microsoft, Optima Molliter, and Sensoria Health later in October 2019.
- Orpyx SI sensory insoles were introduced in December 2019 by Orpyx Medical Technologies Inc., a leader in digital health therapies. These insoles may inform patients in real time and enable them to take action against high-pressure foot areas that could cause tissue breakdown.
- New diabetic footwear from Von Wellex, Germany was introduced in 2021, a footwear that can reduce the possibility of foot issues.
Diabetic Shoes Market Key Companies Profiled
- Asics, Drewshoe, Incorporated, O
- rthofeet Inc.,
- DARCO International, Inc.,
- Clearwell Mobility Company,
- Supad, Aetrex Worldwide, Inc.,
- Gravity Defyer Corp.,
- Kinetec Medical Products Ltd,
- Horng Shin Footwear Co.,
- Watts Footwear, DJO, LLC
- (Dr. Comfort),
- Advanced Diabetic Solution,
- Zen Products, Inc.,
- Sensoria Health
Access the Full Insightful Report from the Diabetic Shoes Market!
Key Segments Covered in the Diabetic Shoes Market Report
By Product Type:
- Dress Shoes
- Running Shoes
- Strolling Shoes
- Others
By Patient Type:
- Outpatient
- Inpatient
By End User:
- Men
- Women
By Width:
- Narrow
- Medium
- Wide
- Others
By Sales Channel:
- Direct Sales
- Footwear Specialty Stores
- Medical & Healthcare Centers
- Online Retailers
- Mono-brand Stores
- Other Sales Channel
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- Asia Pacific Excluding Japan (APEJ)
- Japan
- The Middle East & Africa (MEA)
Author
Sabyasachi Ghosh (Associate Vice President at .) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore the Related Reports from the Diabetic Shoes Markets!
- The diabetic macular edema market is estimated to hold a valuation of around USD 4,120.9 million in 2024. Download the Sample Copy of this Report!
- The diabetic markers market size is projected to be worth US$ 928.1 million in 2023. The market is likely to surpass US$ 2.6 billion by 2033 Download the Sample Copy of this Report!
- The global diabetic ketoacidosis treatment market size is expected to reach US$ 3.5 Billion in 2022 and exhibit growth at a CAGR of 5.7% Download the Sample Copy of this Report!
About the Author:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai and has delivery centers in the UK, U.S., and India. FMI’s latest market research reports and market analysis helps businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact Us
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube